MedTrace Logo

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

NCT06482489 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2025-04-03

No results posted yet for this study

Summary

This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-field MRI.

Conditions

Interventions

DEVICE

Siemens Magnetom Free.Max 0.55T (Siemens Healthineers, Erlangen, Germany).

Performing low-field MRI to evaluate image quality with patients carrying metallic implants and assess the detection of suspicious prostate lesions.

Sponsors & Collaborators

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Ileana Jelescu, Prof · University of Lausanne Hospitals

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-05-31
Completion
2025-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06482489 on ClinicalTrials.gov